|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-319-45594-5 |
003 |
DE-He213 |
005 |
20220118061309.0 |
007 |
cr nn 008mamaa |
008 |
161020s2016 sz | s |||| 0|eng d |
020 |
|
|
|a 9783319455945
|9 978-3-319-45594-5
|
024 |
7 |
|
|a 10.1007/978-3-319-45594-5
|2 doi
|
050 |
|
4 |
|a RC261-271
|
072 |
|
7 |
|a MJCL
|2 bicssc
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
072 |
|
7 |
|a MJCL
|2 thema
|
082 |
0 |
4 |
|a 571.978
|2 23
|
082 |
0 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment
|h [electronic resource] /
|c edited by Mitchell S. Anscher, Kristoffer Valerie.
|
250 |
|
|
|a 1st ed. 2016.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a VI, 305 p. 65 illus., 53 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a 1. Mechanisms of Normal Tissue Response -- 2. The Role of Hypoxia in Radiation Response -- 3. The Role of Cancer Stem Cells in Tumour Radioresponse -- 4. Novel Strategies to Prevent, Mitigate or Reverse Radiation Injury and Fibrosis -- 5. Technology Based Strategies to Enhance the Therapeutic Ratio -- 6. Nitric Oxide Synthase Uncoupling in Tumor Progression and Cancer Therapy -- 7. Aiming the Immune System to Improve the Antitumor Efficacy of Radiation Therapy -- 8. The Role of MicroRNAs in modulating Tissue Response to Radiation -- 9. Adapting Therapy Based on Tumor Response -- 10. NQO1 Bioactivatable Drugs Modify Radiation Responses -- 11. DNA Repair Pathways as a Potential Target for Radiosensitization -- 12. Radiosensitizing Glioma by Targeting ATM with Small Molecule Inhibitors.
|
520 |
|
|
|a This volume will describe recent progress and future directions in radiation oncology and biology research, focusing on strategies designed to improve disease control and reduce the risk of long-term adverse effects on patients. As more and more patients are becoming long-term survivors, this strategy will become increasingly important--in radiation oncology and throughout the field of oncology.
|
650 |
|
0 |
|a Cancer.
|
650 |
1 |
4 |
|a Cancer Biology.
|
700 |
1 |
|
|a Anscher, Mitchell S.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Valerie, Kristoffer.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319455921
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319455938
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319833262
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-319-45594-5
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SBL
|
912 |
|
|
|a ZDB-2-SXB
|
950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|